Thanks to the support we received from our friends, MAX BioPharma was able to conduct a study to explore the effects of oxysterol on hair growth in a very humane mouse model. Our observations from this study are significant and crucial in our ability to decide what additional studies will be needed to further pursue the use of oxysterols in hair growth indications. We hope to have future observations to share about this topic in the near future. Cheers.
About This Project
Hair loss can affect both men and women, often leaving a negative impact on the affected person’s life. Stem cells associated with hair follicles drive normal hair growth but lie dormant in bald spots. We propose to test topical applications of Oxy133, a drug candidate that can safely increase Hedgehog signaling, in a mouse model of hair growth. We hypothesize that dormant hair stem cells will be stimulated by Oxy133, resulting in increased hair growth in mice and (eventual) human testing.
Ask the ScientistsJoin The Discussion
What is the context of this research?
Available drug treatments for hair loss (Propecia, Avodart or Rogaine) are modestly effective at best and often plagued by unpleasant side effects. In male pattern baldness, hormonal and other factors lead to a shortened growth (anagen) phase of the hair follicle, resulting in deactivated hair stem cells and diminished hair growth. To regrow lost hair, it may be possible to reactivate dormant hair stem cells by stimulating their cellular signaling. The Hedgehog signaling pathway provides a cellular signal crucial for hair growth that can trigger hair follicles to reenter an active growth phase. At MAX BioPharma, a startup company based in Santa Monica, California, we have developed Oxy133, a drug candidate that can stimulate Hedgehog signaling through a safe ‘allosteric’ mechanism.*
What is the significance of this project?
It is estimated that 40 million Americans suffer from hair loss.* Most hair loss is actually caused by a lack of hair regrowth rather than the increased shedding of hair. Available treatment options typically work far better to prevent further hair loss than to regrow lost hair. This project will address the question whether Oxy133 can safely stimulate hair stem cells in mice and trigger increased hair regrowth. In principle, this application could translate into a hair growth treatment for humans, as Hedgehog signaling functions similarly across species.* Successful experimental outcomes would then allow us to partner with pharmaceutical and cosmetic companies, as well as investors, to further develop the drug and advance to human testing and eventual commercialization.
What are the goals of the project?
The immediate goal of the project is to test the ability of Oxy133, a sterol based activator of Hedgehog signaling, to enhance hair growth in mice through topical application of the compound, a simple but effective model of hair regrowth. We believe that Oxy133 is highly suited for dermatological applications due its high solubility in skin oil. If successful, this pilot study will provide data that can be presented to potential industry partners and investors who will help us develop the technology for commercialization. The long term goal of this project is to offer a new, safe and effective treatment option to people suffering from hair loss.
There are standard costs that go along with animal experimentation. $5,000 would cover all costs from creating more of the drug candidate for use, housing the mice, paying the scientists, applying the drug, recording the results, and maintaining the lab.
The study will take about 2 months from start to finish. Mice will be purchased from commercial vendors, we will shave their backs and apply the drug candidate daily at two doses for 3 weeks to observe and document hair growth patterns. At the end of the study, if hair regrowth is enhanced with our drug candidate, as we anticipate, we will carry out histological examination of the skin and hair follicles.
Jul 30, 2018
Sep 03, 2018
Nov 02, 2018
Finalize Experiment and Analyze Results
Nov 12, 2018
Meet the Team
At MAX BioPharma, we aim to realize the therapeutic potential of a previously understudied group of lipid molecules, so-called oxysterols, and understand their role in human health and disease. Leveraging combined expertise in the fields of cellular biology, lipid biochemistry and drug discovery, we work to build a new generation of therapeutic agents that can address a number of unmet medical needs.
Dr. Farhad Parhami worked at UCLA as a biomedical researcher and Professor of Medicine for over 22 years. While at UCLA, Farhad first studied the effects of certain sterols, including cholesterol and oxidation products of cholesterol, so called oxysterols, on the cellular signaling of adult stem cells. Remnants from our prenatal period, adult stem cells can be found in all human tissues and are crucial elements for our body’s normal maintenance as well as repair and recovery from injury or disease. For example, skin injuries, such as cuts or bruises, are repaired with help from skin progenitor cells, so called fibroblasts, which become activated during wound healing. Similarly, broken bones heal by drawing in bone progenitor cells that reside in the bone marrow and turn into mature bone cells, so called osteoblasts, near the site of bone injury. Farhad’s research demonstrated that adult stem cells can be activated by oxysterols without affecting other cells that are not stem cells. That is because oxysterols work by stimulating stem cell specific signals, such as Hedgehog signaling, in a safe manner that does not lead to overstimulation, which can be potentially dangerous. This so called “allosteric” activation amplifies only preexisting Hedgehog signals found in the adult stems cells.
- $2,962Total Donations
- $128.78Average Donation